CDMO and Solutions
Striving to apply proprietary technology to promote human health
CDMO and Solutions
/
Research Innovation
CytoNiche Biotech's 3D TableTrix® Microcarrier Receives FDA-DMF Type II Qualification Filing Again
2023 07-27

CytoNiche Biotech's 3D TableTrix® Microcarrier Receives FDA-DMF Type II Qualification Filing Again

Not only Type IV for pharmaceutical excipients, but also Type II for active pharmaceutical ingredients (APIs) and finished drugs!
New! CytoNiche Biotech's 3D TableTrix® Microcarrier Receives 【FDA-DMF】 Qualification Filing
2023 07-25

New! CytoNiche Biotech's 3D TableTrix® Microcarrier Receives 【FDA-DMF】 Qualification Filing

Issued by the Center for Biologics Evaluation and Research (CBER) under the United States FDA, this new qualification filing pertains to vaccines and biologic products, among other areas.
Application of Novel 3D Porous Biodegradable Microcarrier in the Vaccine Field
2023 07-11

Application of Novel 3D Porous Biodegradable Microcarrier in the Vaccine Field

The utilization of 3D TableTrix® Microcarrier V01 in conjunction with 3D FloTrix® Automated Bioreactor presents a more efficient large-scale suspension culture method for Vero cells, offering a new ch
Major Breakthrough: 3D FloTrix® Serum-Free Culture Medium for Mesenchymal Stem Cells Officially Registered with 【DMF】
2023 07-06

Major Breakthrough: 3D FloTrix® Serum-Free Culture Medium for Mesenchymal Stem Cells Officially Registered with 【DMF】

DMF Registration Number: 038476, Facilitating Clinical Submissions for Pharmaceutical Companies!
"Bioactive Materials" Major Research Achievement Published: Dual-functional in-situ self-assembling organoids based on 3D microcarriers for bone-cartilage regeneration
2023 07-04

"Bioactive Materials" Major Research Achievement Published: Dual-functional in-situ self-assembling organoids based on 3D microcarriers for bone-cartilage regeneration

Using 3D TableTrix® microcarriers as a foundation, personalized gelatin microcarriers were designed in vitro, which self-assembled in vivo to form bone-cartilage organoids. These organoids were employ
Frontier Research: [3D Microcarrier] Facilitates Efficacy Verification and Mechanism Exploration in Spinal Cord Injury Regeneration and Repair
2023 06-08

Frontier Research: [3D Microcarrier] Facilitates Efficacy Verification and Mechanism Exploration in Spinal Cord Injury Regeneration and Repair

Abstract: The application of 3D TableTrix® microcarriers and their derivative technologies holds promise for accelerating the translation and promotion of tissue engineering techniques in the field of
【3D Microenvironment】Exploration of Modulating Stem Cell Function
2023 05-25

【3D Microenvironment】Exploration of Modulating Stem Cell Function

Compared to traditional 2D microenvironments, the 3D microenvironment can better replicate key features and functions of the in vivo microenvironment for stem cell cultivation.
New Product Launch | 3D FloTrix® vivaPACK Cell Filling System
2023 05-05

New Product Launch | 3D FloTrix® vivaPACK Cell Filling System

New Product Launch | Prologue: An Introduction to Cell Production and Preparation Process - Cell Formulation Packaging
2023 04-25

New Product Launch | Prologue: An Introduction to Cell Production and Preparation Process - Cell Formulation Packaging

As the final step in the cell production and preparation process, cell formulation packaging plays a crucial role. Any errors or mistakes in this step can undo all the previous efforts and lead to sig
Previous page
1
2
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.